Raymond James Financial’s Inspire Corporate Bond ETF IBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26M Buy
95,153
+15,335
+19% +$366K ﹤0.01% 3401
2026
Q1
$1.9M Buy
79,818
+5,946
+8% +$143K ﹤0.01% 3401
2025
Q4
$1.79M Sell
73,872
-19,415
-21% -$469K ﹤0.01% 3364
2025
Q3
$2.25M Buy
93,287
+3,429
+4% +$82.5K ﹤0.01% 3088
2025
Q2
$2.16M Sell
89,858
-2,630
-3% -$62.4K ﹤0.01% 3023
2025
Q1
$2.2M Buy
92,488
+838
+0.9% +$19.8K ﹤0.01% 2919
2024
Q4
$2.15M Buy
+91,650
New +$2.17M ﹤0.01% 2915

Other funds holding IBD

Raymond James Financial's IBD Position: Q2 2026 in Review

Raymond James Financial increased its Inspire Corporate Bond ETF (IBD) stake by 19% in Q2 2026, buying an estimated $366K and bringing the position to 95,153 shares worth $2.26M. The position accounts for ﹤0.01% of the portfolio, ranked #3401.

Raymond James Financial first reported a position in IBD in Q4 2024 and has held it in 7 quarters since. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.

  • Raymond James Financial held 95,153 shares of Inspire Corporate Bond ETF worth $2.26M as of Q2 2026.
  • Raymond James Financial bought 15,335 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $366K.
  • Inspire Corporate Bond ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3401 holding.
  • Raymond James Financial first reported a position in Inspire Corporate Bond ETF in Q4 2024 and has held it in 7 quarters since.
  • 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.